Screener
Generate Biomedicines, Inc.
GENBGenerate Biomedicines, Inc. is a asset management company in the financial services sector trading on XNAS, led by CEO Michael T. Nally, with a market cap of $1.8B.
Earnings
Next report
Feb 11, 2027 (in 3 months)Revenue estimate$6.3M
EPS estimate-$0.67
Financials
Q3 2026Valuation & ratios
Profile
CountryUnited States of America
Listed2026
CEOMichael T. Nally
SectorFinancial Services
IndustryAsset Management
Websitegeneratebiomedicines.com
FilingsSEC EDGAR
FAQ
- What is Generate Biomedicines, Inc.'s market cap?
- Generate Biomedicines, Inc. (GENB) has a market capitalization of $1.8B and trades on XNAS.
- Where is Generate Biomedicines, Inc. headquartered?
- Generate Biomedicines, Inc. is headquartered in United States of America. It has been publicly traded since 2026.